Terra Clean Energy Corp. Acquires and Digitizes Extensive Historic Database for the Marysvale Uranium Mines Project, Utah, United States

Vancouver B.C., Aug. 10, 2026 (GLOBE NEWSWIRE) — TERRA CLEAN ENERGY CORP. (“Terra” or the “Company”) (CSE: TCEC, OTCQB: TCEFF, FSE: C9O0) is pleased to announce that it has completed the acquisition, compilation and digitization of a significant historical exploration database for its 100%-owned Marysvale Uranium Mines located in the historic Marysvale Uranium District, Utah. The project includes the past-producing Prospector and Freedom uranium mines, which historically accounted for a substantial portion of the district’s uranium production of 1.33 Mlbs U3O8 at reported average grades of 0.22% * (Terra Clean Energy Corp.)

Quantum Cyber Files Lawsuit Against White Diamond Research, Adam Gefvert and Stocktwits, Inc. in New York Supreme Court

Complaint Asserts Market Manipulation, Conspiracy, and Defamation; Alleges White Diamond Buried Its Short-Selling Disclosure on an Obscure Webpage While Stocktwits Amplified the White Diamond Report to Millions of Readers Without Disclosing the Author’s Own Potential Short Position. CEO Lazar: “We intend to hold every defendant accountable in a court of law”

Complaint Asserts Market Manipulation, Conspiracy, and Defamation; Alleges White Diamond Buried Its Short-Selling Disclosure on an Obscure Webpage While Stocktwits Amplified the White Diamond Report to Millions of Readers Without Disclosing the Author’s Own Potential Short Position. CEO Lazar: “We intend to hold every defendant accountable in a court of law”

OSGear Introduces Updated Information Resources for Oral Steroids and Performance Research Products

New York, USA, Aug. 10, 2026 (GLOBE NEWSWIRE) — Osgear has introduced updated information resources focused on oral steroids, performance research products, and related industry knowledge. The announcement highlights expanded educational material designed to provide structured information regarding product categories, research considerations, regulatory awareness, and responsible evaluation practices within the performance research sector.

Greenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027

STAFFORD, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced that its Board of Directors has extended the lock-up of the shares owned by the Company’s directors, officers, and existing pre-IPO investors to January 31, 2027 which is approximately 76 months from the date of the Company’s IPO. During this period, current officers, directors and certain shareholders will not be able to sell their shares of the Company’s common stock unless otherwise modified by the Board of Directors. After January 31, 2027, the quantity of these locked-up shares that can be sold daily and over various periods of time will be restricted under a leak-out plan unless otherwise modified by the Board of Directors.

TJGC Group Limited in Negotiations for AI and Robotics Technology License

HONG KONG, Aug. 10, 2026 (GLOBE NEWSWIRE) — TJGC Group Limited (Nasdaq: TJGC) (the “Company”) today announced it is negotiating a potential intellectual property license agreement with a robotics technology provider. The parties hope to enter into a definitive agreement granting the Company non-exclusive, worldwide rights to commercialize certain artificial intelligence and robotics technologies in intelligent automation products.